Overview of Dr. Tezel
Tongalp Tezel, MD, is an Ophthalmologist based in New York, NY, with subspecialties in Retinal Disease and Uveitis. His education includes an internship in Internal Medicine at SSM St Mary's Hospital-St Louis (1998-1999), a residency in Ophthalmology at Washington University/B-JH/SLCH Consortium (1999-2002), and graduation from Hacettepe University FOM in 1984. Dr. Tezel has substantial experience in fields like macular edema, optical coherence tomography, glaucoma and related disorders, retina surgery, and vitreoretinal disease. His research in these areas is well-published and cited in respected journals like Translational Vision Science & Technology and Plos One. Dr. Tezel is a distinguished Fellow of the American Society of Retina Specialists and the American Academy of Ophthalmology.
Office
635 W 165th St
New York, NY 10032Fax+1 212-305-5523
Education & Training
- Washington University/B-JH/SLCH ConsortiumResidency, Ophthalmology, 1999 - 2002
- SSM St Mary's Hospital-St LouisInternship, Internal Medicine, 1998 - 1999
- Hacettepe University FOMClass of 1984
Certifications & Licensure
- NY State Medical License 2002 - 2026
- IN State Medical License 2011 - 2015
- KY State Medical License 2003 - 2014
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Fellow of American Society of Retina Specialists
- Fellow (FAAO) American Academy of Ophthalmology
Publications & Presentations
PubMed
- 253 citationsMetastatic disease from uveal melanoma: treatment options and future prospectsRichard D. Carvajal, Gary K. Schwartz, Tongalp H Tezel, Brian P. Marr, Jasmine H. Francis
The British Journal of Ophthalmology. 2017-01-01 - 22 citationsAge-related changes in human RPE cell density and apoptosis proportion in situ.Lucian V Del Priore, Ya-Hui Kuo, Tongalp H Tezel
Investigative Ophthalmology & Visual Science. 2002-10-01 - 160 citationsIs There Tachyphylaxis to Intravitreal Anti-Vascular Endothelial Growth Factor Pharmacotherapy in Age-Related Macular Degeneration?Shlomit Schaal, Henry J. Kaplan, Tongalp H. Tezel
Ophthalmology. 2008-12-01
Press Mentions
- Phase 2 Clinical Trial Is Now Open at Columbia to Test Gene Therapy for Dry Macular DegenerationMarch 9th, 2021
- ILM Peeling with Retinal Staining Aids Macular Hole ClosureApril 10th, 2017
Grant Support
- Proteomic Analysis Of Age-Related Macular DegenerationNational Eye Institute2005–2007
Professional Memberships
- Fellow
- Member
- Member
- The Retina SocietyMember
- The Macula SocietyMember
- The Association for Research in Vision and OphthalmologyFellow
Other Languages
- German, French, Turkish
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
Anthem Blue Access PPO
Anthem Blue Preferred HMO
BCBS Blue Card PPO
BCBS Illinois PPO
CIGNA HMO
CIGNA PPOFirst Health PPO
Great West PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
Sagamore Health Plus
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: